In The News

Reformulary 2020 Year in Review

In 2020, we redefined value within drug plans saving Canadian organizations money and paving a sustainable path. Making sense of medicine was all the more important during the COVID-19 pandemic.

We have several exciting things in the works for 2021, so keep in touch with us via LinkedIn, Twitter or by visiting the news section of our website regularly.

Click the image below to view the full 2020 Year-in-Review.

Reformulary-Group 2020 Year-in-Review